Tired of ads? Enjoy an ad-free experience by signing up.
👩‍🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔‍♂️ A friendly human may check it before it goes live. More news here

Chinese lidar maker Hesai said to eye $300m Hong Kong listing

Hesai Group plans to list its shares in Hong Kong as early as next month, according to sources familiar with the matter.

The Shanghai-based company, which makes lidar sensors for vehicles and is already listed on Nasdaq, is targeting a US$300 million raise.

The deal size and timing could still change, the sources said.

Hesai recently received approval from China’s securities regulator to list up to 51.2 million ordinary shares in Hong Kong.

The company confidentially filed for the listing.

If completed, Hesai could be among the first US-listed Chinese firms to seek a Hong Kong listing after renewed delisting risks in the US this year.

🔗 Source: Bloomberg


🧠 Food for thought

1️⃣ Dual listings offer Chinese companies insurance against geopolitical risks

Hesai’s Hong Kong listing represents a growing hedge strategy among Chinese companies facing potential US delisting pressures.

The company already trades on Nasdaq but is seeking to raise $300 million in Hong Kong, positioning itself alongside other US-listed Chinese firms like Atour Lifestyle Holdings that are pursuing similar dual-listing strategies1.

This approach allows companies to maintain access to US capital markets while creating alternative fundraising channels if regulatory tensions escalate.

The strategy has become particularly relevant as US-China tensions have created uncertainty around Chinese companies’ long-term access to American exchanges, making diversified listing locations a form of financial risk management.

2️⃣ Hong Kong’s regulatory flexibility attracts innovative Chinese companies

Hong Kong’s stock exchange has positioned itself as an attractive alternative by adapting regulations to accommodate emerging technology companies.

The exchange allows companies in innovative sectors like biotech to list without operational revenue and accepts weighted voting rights structures, creating more flexible pathways for tech companies2.

Stay ahead in Asia’s tech landscape

You've reached your 2 free content limit for the month. Sign up for free to read the full story.

🏄 For casual readers / 👶 Free

Basic

US$0

Free forever

Get instant access to this article and more every month

0 premium content

Unlimited news briefs

5

5 articles

Ad-free reading experience

Just US$0 per day

⌛Sign up in 20s. No payment details needed.

📖 For learners / 👍 Starter

Lite

US$4.92/month

Billed annually at US$59/year

Get instant access to this article and more every month

4

4 premium content

Unlimited news briefs & articles

Ad-free reading experience

Just US$0.17 per day

Cancel anytime

Our subscriber community includes professionals from these companies:

Stay updated on the go with our mobile app.

Get latest insights with smoother, more personalized experience through TIA mobile app.